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Abstract
A case of prenatally diagnosed, giant cord hemangioma is reported, which was accompanied by the elevation of
maternal serum alpha-fetoprotein (MS-AFP) and human chorionic gonadotropin (MS-hCG) levels. A 30-year-old
woman without a previous history of gravida or para, presented with intermittent abdominal pain at 26 weeks of
gestation. Doppler studies showed the fetus developing heart failure as the tumor grew larger. Caesarian section
was performed at 29 weeks of gestation. Macroscopic examination of the placenta revealed a 17.0 × 10.0 × 7.0 cm
tumor localized at the placental end of the umbilical cord. Microscopically, the tumor was composed of small arborizing
vessels proliferating in the myxoid background, and the tumor cells were positive for AFP by immunohistochemistry.
Extramedullary hematopoiesis was seen in the tumor vascular channels. The present case is one of the largest umbilical
cord hemangiomas reported in the literature, and the first hemangioma case with MS-hCG elevation, extramedullary
hematopoiesis, and positive AFP staining in the cord hemangioma. Its clinical course and detailed pathological findings
are presented along with a review of the related literature.
Background
While hemangioma of the placenta is sometimes seen,
hemangioma of the umbilical cord is very rare. The clin-
ical and pathological significance of cord hemangioma
remains unclear due to its rarity, and thus an antenatal
management regimen remains unestablished. Papadopoulos
et al. found 60 % of cord hemangiomas were accompanied
by increased maternal serum alpha-fetoprotein (MS-AFP)
[1]. The cause of MS-AFP elevation is not understood, but
several authors postulated there is a breakdown of the fetal/
amniotic fluid barrier due to cord hemangioma, similar to
other conditions with MS-AFP elevation such as neural
tube defects, cystic hygromas, and omphaloceles [1–3]. On
the other hand, maternal serum human chorionic gonado-
tropin (MS-hCG) elevates in cases of multiple pregnancy,
hydatidiform mole, and trisomy 21, although there has
been no report of cord hemangioma with increased
MS-hCG. Cord hemangiomas are assumed to increase
the risk of perinatal mortality and morbidity [4–8], be-
cause they are often associated with intra-uterine fetal
death [2, 5, 6, 9–13]. However, some authors have spec-
ulated that there is a falsely strong relationship between
neonatal morbidity and cord hemangioma because
complicated pregnancies tend to be thoroughly exam-
ined [14]. In the latest review by Papadopoulos et al.,
the authors concluded that intra-uterine fetal deaths
caused by cord hemangiomas are rare, and they are more
frequently reported when a fetal anomaly co-exists [1].
We report a case of a prenatally diagnosed giant um-
bilical cord hemangioma, followed with Doppler studies
and associated with elevation of MS-AFP and MS-hCG.
The delivery was conducted by Caesarian method at
29 weeks of gestation due to fetal heart failure. This case
report focuses on the pathological findings of the cord
hemangioma and also contributes for clarifying its clini-
copathological significance.
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A 30-year-old woman without previous experience of
gravida and para, presented with intermittent abdominal
pain at 26 weeks of gestation. She had no significant
medical history. An intrauterine mass measuring 4 cm
in diameter was detected by ultrasound scan. In the 27th
week, the mass grew to 10 cm in diameter and she was
referred to Juntendo University Hospital. Ultrasound
scan and MRI showed a solid mass, 10.0 × 9.6 × 9.0 cm,
located at the placental end of the umbilical cord
(Fig. 1a). Blood flow was confirmed within a mass which
synchronized with fetal heartbeat. No anomaly was iden-
tified in the fetus. Laboratory data revealed elevated MS-
AFP (4,886 ng/ml) and hCG (182,396 mlU/ml). Hepatic le-
sion, ovarian tumor or possible AFP producing tumor of
the other site was not evident by ultrasound scan and MRI.
At the 29th week, the mass grew to 17.0 × 15.0 × 11.5 cm.
Ultrasound scan and Doppler study showed increased fetal
preload index and cardiothoracic area ratio, indicating fetal
heart failure (Table 1). Two days later, Caesarian section
was performed. The infant weighed 1,086 g with Apgar
score of 6/8 at 1 and 5 min, respectively. A smooth and
solid mass was noticed at the umbilical cord attached to
the edge of the placental disc (Fig. 1b). The infant was
subsequently transferred into the Neonatal Intensive
Care Unit. Physical examination showed no superficially
observed hemangioma or other congenital anomalies.
Chromosome aberration was not detected in the infant
or the mass lesion.
Macroscopic findings
The placenta and its umbilical cord were submitted to
the pathological department. The placental disc weighed
1,200 g and measured 23.5 × 20.0 × 7.0 cm in total. The
umbilical cord was attached to the edge of the placental
disc and contained a smooth and solid mass, which was
17.0 × 10.0 × 7.0 cm and located close to its placental
end. A 7 mm segment of normal umbilical cord was
present between the mass and the placental cord insertion.
The mass was encapsulated by the amniotic membrane.
The cut surface of the mass was solid, myxomatous, and
light brown in color (Fig. 2a). Thrombi and calcified foci
were rarely seen at the periphery of the mass. Inside the
mass, three umbilical vessels were identified. These vessels
were dispersed in the mass but otherwise normal-looking
without obstruction or stenosis (Fig. 2a). As for the non-
tumorous umbilical cord, marked edematous change was
seen from the mass to 15 cm fetal side, while no remark-
able change was seen for the remaining part. There was
no mass in the placental disc.
Fig. 1 Clinical findings of cord hemangioma. a Fetal magnetic resonance imaging (MRI) performed at 27th week of gestation. The solid mass
lesion was identified close to but not attaching to the placental disc. Note the umbilical vessels are identified within the mass. b Macroscopic
appearance of umbilical cord and placental disc before formalin fixation. The large and solid mass is seen at the placental end of the umbilical
cord (Arrow heads)
Table 1 Data from Ultrasound scan and Doppler study
GAa 27w5dd 28w1dd 29w2dd
Mass sizeb (cm) 10.0 × 9.6 × 9.0 13.8 × 12.6 × 9.9 17.0 × 15.0 × 11.5
PLIc NA 0.25 0.47
CTARdc 30 32.2 55.3
aGA, Gestational age
bMass size, presented in centimeter
cPLI, Prelord index; NA, not available
dCTAR, Cardiothoracic area ratio (%)
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Microscopic findings
The mass was composed of small and arborizing vessels
proliferating in the background of myxoid stroma or
Wharton jelly (Fig. 2b). Tumor cells were small and
round to spindle-shaped with no significant nuclear aty-
pia. Mitotic figures were seldom seen. Within the tumor,
non-tumorous vessels including umbilical vein/arteries
were kept intact; there was no invasion by the tumor to
the fibrous wall of the original vessels (Fig. 2c). Immuno-
histochemical staining was performed using the following
antibodies: CD31 (1:50; JC70A, Dako, Grostrup, Denmark),
CD34 (1:200; My10/8G12, BD Transduction Laboratories,
Franklin Lakes, NJ, USA), von Willebrand factor (1:3000;
polyclonal, Dako), AFP (1:50; C3, Leica Biosystems,
Nussloch, Germany) and hCG (1:1000; polyclonal,
Leica Biosystems). Immunohistochemically, the tumor
cells were positive for CD31, CD34 and von Willebrand
factor. Tumor cells were positive for AFP (Fig. 2d),
while original umbilical vessels were negative. There
were no hCG-positive cells within the tumor.
The non-tumorous portion of the umbilical cord was
partially edematous, but there was no anomaly found.
As an additional finding, nucleated erythrocytes and my-
elocytes were often seen in the tumorous vessels, indicat-
ing extramedullary hematopoiesis of the tumor (Fig. 3a).
These hematopoietic cells were also identified in the ori-
ginal umbilical vessels and capillaries in the placental villi,
suggesting the communication between tumorous vessels
and fetus-feeding vessels (Fig. 3b). There was no evident
pathological change in the placental disc; it was composed
of mature villi without evidence of chorioamnionitis or in-
farcted foci.
Fig. 2 Pathological findings of cord hemangioma. a Cut surface of
cord hemangioma, showing a tan-colored and solid mass containing
umbilical vessels (arrows). b Representative histology of the cord
hemangioma. The tumor consists of small, arborizing and thin-walled
vessels (Hematoxylin and eosin staining). c Original umbilical artery
(left side) passes through the tumor. The tumorous vessels never
invade to the original umbilical vessels. d Endothelial cells of the
tumor are immunohistochemically positive for AFP
Fig. 3 Extramedullary hematopoiesis in cord hemangioma. a Immature myeloid/erythroid cells (arrows) in tumorous vessels. b Nucleated
erythroblasts/myeloid cells (arrows) in capillary of placental villi
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Discussion
In the present case, the mass was located at the umbil-
ical cord 7 mm from its placental insertion. The mass-
forming lesions of the umbilical cord include hematoma,
thrombosis, varices, aneurysms, and hemangioma. It was
relatively easy to diagnose this case as hemangioma
pathologically, differentiating the other mass-forming le-
sions because of the monotonous proliferation of small
vessels and the intact-looking original cord vessels seen
in this case.
The present case is a giant cord hemangioma which
was detected at 24 weeks of gestation and followed for
5 weeks with Doppler studies; the fetus was safely deliv-
ered by Caesarean method at the 29th week. A PubMed
search of the literature published since 1960 revealed
that cord hemangiomas range from 0.2 to 13 cm in
diameter, making the present case one of the largest
cord hemangiomas ever [1]. This case is worth reporting
because of its unique gestational course with MS-hCG
elevation and fetal heart failure associated with cord
hemangioma. Pathologically, immunoreactivity for AFP
and extramedullary hematopoiesis (EMH) within the
tumor vessels are also of value.
MS-AFP elevation has been detected in the majority
of reported cord hemangiomas [1]. Though the exact
mechanism of MS-AFP elevation has not yet been iden-
tified, several authors speculated it may be due to the
breakdown of the fetal/amniotic fluid barrier due to cord
hemangioma, since MS-AFP also increases when the fetus
has neural tube defects, cystic hygromas and omphaloceles
[1–3]. The immunoreactivity of the hemangioma cells for
AFP in this case suggested the AFP-producing nature of
the umbilical cord hemangioma. AFP is prenatally pro-
duced in the yolk sac of the embryo. Some tumors pro-
duce AFP, including hepatocellular carcinoma, some germ
cell tumors, and hepatoid carcinoma arising from several
organs. As for vascular tumors, hepatic hemangioendothe-
lioma has been reported for its association with high
serum AFP, though it is controversial if AFP elevation is
due to the production by the tumor itself or is a hepatic
response to the tumor [15].
Although an increase in MS-hCG was seen in the
present case, hCG producing cells were not detected
within the tumor by immunohistochemistry, despite the
use of the appropriate positive control. There have been
no reports of MS-hCG elevation associated with umbilical
cord hemangioma. hCG is mainly produced by syncytio-
trophoblasts covering placental villi during pregnancy.
MS-hCG elevation sometimes indicates aneuploidy preg-
nancies, mostly trisomy 21, hence measurement of serum
free beta-human chorionic gonadotropin is now utilized in
combination with AFP, unconjugated estriol and inhibin
alpha to screen for abnormal pregnancy. Since there was
no anomaly found in the infant and its placental disc or
the mother associated with high MS-hCG concentration,
the cord hemangioma might be responsible for MS-hCG
elevation in the present case. The instability of fetal and
placental circulation caused by the cord hemangioma may
influence the hCG release into the maternal blood. It will
be clinically important to determine if cord hemangiomas
also account for high MS-hCG concentrations.
This is the first report showing EMH in cord
hemangioma. There are several reports of EMH in hem-
angiomas arising from other adult organs, including kid-
ney [16–19], skin [19–21], spleen [22], small bowel [23],
and adrenal gland [24]. Some of these reports suggested
that hemangioma can potentially generate hematopoietic
precursor cells [20, 21], based on a study showing that the
common precursor cell differentiated into both vascular
endothelial and hematopoietic cells [25]. In addition, our
precise pathological examination revealed that original
umbilical cord vessels and placental capillaries also con-
tained nucleated erythroblasts and myelocytes, suggesting
that extramedullary hematopoietic cells entered into the
fetal circulation.
Several kinds of vessels have been proposed as candi-
dates for the origin of cord hemangioma, including um-
bilical artery, umbilical vein, capillaries in Wharton jelly
and vitelline capillaries [1, 12]. The vessels in close prox-
imity to the tumor or encompassed by the tumor have
been considered to be the origin of the tumor in previ-
ous studies. Since there was no close interaction be-
tween tumor vessels and umbilical vessels in the current
case, the tumor origin may have been capillaries in the
Wharton jelly.
Although several reports have proposed the possibility
that cord hemangiomas impair the fetal circulation, the
clinical and pathological significance of this rare tumor
remains obscure. Our prenatal data showed the size of
the tumor and fetal congestive state were well correlated,
therefore we postulate that mechanical compression of
the umbilical vein by the tumor mass is the most plaus-
ible reason for the deterioration of the fetal congestive
state. This mechanical compression of the umbilical ves-
sels has been previously proposed as a factor responsible
for impaired fetal circulation [10]. In addition, there are
several theories relating to how cord hemangioma affects
the fetal circulation, including acting as a shunt and
leading to fetal heart failure [26], and the tumor’s inward
growth to the umbilical vessels resulting in stenosis [6].
Cord hemangiomas result in increased fetal morbidity
and mortality, and have been associated with hydram-
nios, hydrops fetalis, and fetal hemorrhage from a rup-
tured hemangioma. However, some authors speculate
that fetal anomalies co-existing with cord hemangioma
may be responsible for fetal morbidity, and cord
hemangioma itself is not always lethal to the fetus [1, 6].
The clinical significance of cord hemangioma remains to
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be determined. Doppler study is effective for evaluating
the fetal congestive state in prenatally diagnosed cord
hemangiomas.
Conclusion
This case presents the clinical data and detailed patho-
logical features of a rare, giant, prenatally diagnosed cord
hemangioma accompanied by rare phenomenon such as
extramedullary hematopoiesis and elevation of MS-hCG.
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